A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology

By afschroeder • August 3, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi M, Chung MK, Ellenbogen KA, Taylor RS. A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology. Heart Rhythm. 2025 Aug;22(8):e492-e499. doi: 10.1016/j.hrthm.2025.02.038. Epub 2025 Feb 26. PMID: 40021073; PMCID: PMC12317828.

Tags: Biomarker, Cardiology/Epi, Cedars Sinai DoM, Checklist, Clinical Trial, Outcome, Publications, Randomized Controlled Trial, Research design, standards, Surrogate end point, surrogate marker

Early Structural Deterioration of a Self-Expanding Transcatheter Aortic Valve Prosthesis Presenting With Severe Aortic Insufficiency: A Case Report

Dave PR, Hacobian M. Early Structural Deterioration of a Self-Expanding Transcatheter Aortic Valve Prosthesis Presenting With Severe Aortic Insufficiency: A Case Report. Cureus. 2025 Sep[...]

Comorbidity patterns and mortality in HFpEF: A retrospective longitudinal cohort study

Yousufuddin M, Ma Z, Barkoudah E, Tahir MW, Yazdanyar A, Chikkanna R, Benkhadra K, Bhagra S, Fonarow GC, Yamani MH. Comorbidity patterns and mortality in[...]

Lipoprotein(a), family history, and incidence of premature ASCVD events in a pooled US cohort

Fan Y, Fan W, Hu X, Tsai MY, Hoogeveen RC, Budoff MJ, Wong ND. Lipoprotein(a), family history, and incidence of premature ASCVD events in a[...]